1, Gorshkov K, et al. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis.ACS nano, PubMed ID: 32845122
2, Azad T, et al. Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 Spike for viral entry.Molecular therapy : the journal of the American Society of Gene Therapy, PubMed ID: 33578036
3, Zhao M, et al. Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.PLoS pathogens, PubMed ID: 34166473
4, Underwood AP, et al. Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19.EBioMedicine, PubMed ID: 34419923
5, Heggestad JT, et al. Rapid test to assess the escape of SARS-CoV-2 variants of concern.Science advances, PubMed ID: 34860546
6, Sølund C, et al. Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA-mRNA or Vector-mRNA COVID-19 Vaccines.Vaccines, PubMed ID: 35062736
7, Jang HJ, et al. Remote Floating-Gate Field-Effect Transistor with 2-Dimensional Reduced Graphene Oxide Sensing Layer for Reliable Detection of SARS-CoV-2 Spike Proteins.ACS applied materials & interfaces, PubMed ID: 35593886
8, Yang C, et al. Inhibitory activities of alginate phosphate and sulfate derivatives against SARS-CoV-2 in vitro.International journal of biological macromolecules, PubMed ID: 36481336
9, Pereira de Jesus BA, et al. In Vitro Diagnostic Assay to Detect SARS-CoV-2-Neutralizing Antibody in Patient Sera Using Engineered ACE-2 Mini-Protein.Viruses, PubMed ID: 36560827
10, Lu S, et al. The rapid and highly parallel identification of antibodies with defined biological activities by SLISY.Nature communications, PubMed ID: 36596784
11, Jang HJ, et al. Rapid, Sensitive, Label-Free Electrical Detection of SARS-CoV-2 in Nasal Swab Samples.ACS applied materials & interfaces, PubMed ID: 36938607
12, Gomes MPB, et al. Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials.Viruses, PubMed ID: 37515173
